| Pharmaceutical active ingredients: |
| Tretinoin |
| Available forms, composition and doses of Retinei: |
| N / A |
| Retinei medical category: |
| Human:Acne treatment preparationsCell stimulants and proliferantsCytotoxic chemotherapyDermatologicalsEmollients and skin protectives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D10AD01 - TretinoinL01XX14 - Tretinoin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Janssen |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Reminyl Prolonged Release | Galantamine Hydrobromide | Janssen |
| Remivox | Lorcainide Hydrochloride | Janssen |
| Renova | Tretinoin | Janssen; Johnson & Johnson; Merck; Ortho McNeil Pharmaceuticals; Zuellig Pharma |
| Retardin | Diphenoxylate Hydrochloride | Janssen |
| Retin-A | Tretinoin | Janssen; DKSH; Edward Keller; Four Star; Grunenthal; Johnson & Johnson; Merck; Ortho McNeil Pharmaceuticals; Zuellig Pharma |
| Retinova | Tretinoin | Janssen; Ethicon; Johnson & Johnson; Zuellig Pharma |
| Rhinopront N | Carbinoxamine Maleate; Phenylephrine Hydrochloride | Janssen |
| Rinomar | Pseudoephedrine Hydrochloride | Janssen |
| Risperdal | Risperidone Tartrate | Janssen; Ethnor; Johnson & Johnson; Organon; Ortho McNeil Pharmaceuticals; Zuellig Pharma |
| Risperdal Consta | Risperidone | Janssen; Alkermes; DKSH; Four Star; Ortho McNeil Pharmaceuticals; Vetter Pharma-Fertigung; Zuellig Pharma |